TY  - JOUR
AU  - Calandre, Elena P.
AU  - Hidalgo-Tallon, Javier
AU  - Molina-Barea, Rocio
AU  - Rico-Villademoros, Fernando
AU  - Molina-Hidalgo, Cristina
AU  - Garcia-Leiva, Juan M.
AU  - Dolores Carrillo-Izquierdo, Maria
AU  - Slim, Mahmoud
PY  - 2021
DO  - 10.3390/ph14101063
UR  - https://hdl.handle.net/10668/26606
T2  - Pharmaceuticals
AB  - Gastrointestinal symptomatology is frequent among patients with fibromyalgia, which increases disease burden and lacks specific treatment, either pharmacological or non-pharmacological. We aimed to evaluate the efficacy and tolerability of a...
LA  - en
PB  - Mdpi
KW  - fibromyalgia
KW  - gastrointestinal symptoms
KW  - probiotic
KW  - VSL#3(R)
KW  - efficacy
KW  - tolerability
KW  - Irritable-bowel-syndrome
KW  - Spanish version
KW  - Metaanalysis
KW  - Responses
KW  - Safety
TI  - The Probiotic VSL#3(R) Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
TY  - research article
VL  - 14
ER  -